Truist has initiated coverage of Larimar Therapeutics (NASDAQ:LRMR) with a buy rating, citing an "asymmetric" risk/reward ahead of regulatory updates for its drug candidate nomla for Friedreich’s ...
Wednesday afternoon, a massive police presence was observed by Chopper 9 Skyzoom outside a bank in Ballantyne.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback